Summit Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Summit Financial's LLY Position: Q1 2026 in Review
Summit Financial increased its Eli Lilly (LLY) stake by 86% in Q1 2026, buying an estimated $13.3M and bringing the position to 28,323 shares worth $26.1M. The position accounts for 0.33% of the portfolio, ranked #58.
Summit Financial first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Summit Financial held 28,323 shares of Eli Lilly worth $26.1M as of Q1 2026.
- Summit Financial bought 13,074 Eli Lilly shares in Q1 2026, an estimated $13.3M.
- Eli Lilly made up 0.33% of Summit Financial's portfolio in Q1 2026, its #58 holding.
- Summit Financial first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.